The Use of Extended Platelet Rich Fibrin in Lateral Sinus Augmentation
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: lateral sinus lift with using allograft and collagen membrane, lateral sinus lift with using exteneded platelet rich fibrin.
- Who it may be relevant to
- Registry conditions: Sinus Lift Augmentation. Basic parameters: 20 years — 60 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Extended Platelet Rich Fibrin in Lateral Maxillary Sinus Lifting With Simultaneous Implant Placement.
Overview
thirty implants will be inserted in patients seeking implantation of their lost posterior maxillary teeth (premolar and molars) with limited bone height below the floor of the maxillary sinus, secondary to sinus pneumatization. The patients will be selected from those attending the outpatient clinic of the Oral \& Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University. 1. Clinical Evaluation • Implant stability 2. Radiographic Evaluation Vertical bone gain (VBG)
Interventions
- Procedure lateral sinus lift with using allograft and collagen membrane
sinus floor elevation with placing allograft and collagen membrane - Procedure lateral sinus lift with using exteneded platelet rich fibrin
sinus floor elevation with placing eprf
Primary outcome measures
- implant stability [Time frame: 9 months]
- Vertical bone height [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- Patent ostium of maxillary sinus.
- Patient with missing one or more posterior maxillary teeth.
- Residual bone height of 3-6 mm, measured from the crest of alveolar ridge to the floor of the maxillary sinus at the planned implant site.
- A ridge width at the site of implantation of <5mm.
- Platelets of normal range.
- Good oral hygiene.
- Patients in the age frame between 20 years and 60 years old.
- No gender preface in selection of the patients.
- A minimum crown height space of 8 mm.
Exclusion criteria
- Active sinusitis, cyst, tumors or root tips at the planned surgical site.
- Patients with systemic diseases that contra-indicate the surgical procedure such as uncontrolled diabetes mellitus, bleeding disorders, serious osseous disorders, and mental disorders.
- Heavy smoking and alcoholism.
- Parafunctional habits such as bruxism and clenching.
- Signs of acute infection or pus discharge.
- Disturbed occlusion.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- MANSOURA University — Al Mansurah
Identifiers
NCT: NCT06626776 · A0102024OS